Get started
Author

Pamela A. Kreinest

Secreted Frizzled-Related Protein 1 Loss Contributes to Tumor Phenotype of Clear Cell Renal Cell Carcinoma
2007 · Michelle L. Gumz, Hongzhi Zou, et al. · Clinical Cancer Research · 297
Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma
2010 · Han W. Tun, Laura A. Marlow, et al. · PLoS ONE · 178
PDF
A p120 Catenin Isoform Switch Affects Rho Activity, Induces Tumor Cell Invasion, and Predicts Metastatic Disease
2008 · Masahiro Yanagisawa, Deborah Huveldt, et al. · Journal of Biological Chemistry · 174
PDF
Pathway analysis of primary central nervous system lymphoma
2008 · Han W. Tun, David Personett, et al. · Blood · 166
Novel high-affinity PPARγ agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1
2005 · J A Copland, L A Marlow, et al. · Oncogene · 133
Oncogenic K‐ras promotes early carcinogenesis in the mouse proximal colon
2008 · Shelly R. Calcagno, Shuhua Li, et al. · International Journal of Cancer · 68
PDF
The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro
2013 · Marie N. Becker, Kevin J. Wu, et al. · Urologic Oncology Seminars and Original Investigations · 30
Lower expression levels of the transforming growth factor beta receptor type II protein are associated with a less aggressive tumor phenotype and improved survival among patients with clear cell renal cell carcinoma
2006 · Alexander Scott Parker, Christine M. Lohse, et al. · Human Pathology · 14
An Examination of the Association between FOXA1 Staining Level and Biochemical Recurrence following Salvage Radiation Therapy for Recurrent Prostate Cancer
2016 · Michael G. Heckman, Jessica L. Robinson, et al. · PLoS ONE · 2
PDF
Loss of Expression of the Vitamin D Receptor in Clear Cell Renal Cell Carcinoma
2009 · Alexander S. Parker, Timothy J. Leroy, et al. · The Journal of Urology · 1
Works count: 10
Citation count: 1,063
H-index: 8
I10-index: 8
Year
Topic
Type